Updates
Updates on our work to establish “one standard” in the treatment of epilepsy and associated psychiatric disorders around the world.
May 15, 2019
In 2017, two Loma Linda University Health (LLUH) physicians travelled to Malawi, a country of 18 million in southeastern Africa. They helped install a new EEG system and launch an epilepsy monitoring unit at Malamulo Hospital, a 250-bed facility in rural southern Malawi.
April 30, 2019
We are excited to present our first Annual Program Report. 2018 was an exceptionally exciting year for us and also a year of many “firsts” for the foundation.
March 26, 2019
In keeping with our mission to improve the lives of people living with epilepsy and associated psychiatric disorders in under-resourced regions, we are happy to announce a partnership with The HAPPINESS Project.
February 20, 2019
In January I had the pleasure of traveling with Dr. Jeff Loeb, the Head of the Department of Neurology and Rehabilitation at the University of Illinois at Chicago (UIC), and Dr. Jesica Herrick, an infectious disease doctor at UIC, to the Hospital de Niños in Santa Cruz, Bolivia.
January 15, 2019
The ROW Foundation has donated enough of the antiepileptic drug (AED) Roweepra to cover 63,000 months of treatment. We can’t know for sure how many children and adults in underserved parts of the world are benefiting from our medication grants, but the number is growing rapidly.
December 18, 2018
This has been an exciting year for the ROW Foundation. That makes it difficult deciding what should be the focus of this year-end letter. I’ve settled on three chapters from our 2018 story that make me especially proud and grateful to be part of the ROW Foundation.
November 19, 2018
EPILEPSY is the most common serious brain disorder worldwide with no age, racial, social class, or geographic boundaries. There are 3.4 million people in the US living with active epilepsy. That's more than Autism Spectrum Disorders, Parkinson's, Multiple Sclerosis and Cerebral Palsy combined. Yet, epilepsy...
October 18, 2018
FATIMA HAS HAD EPILEPSY since the age of three. For 30 years the treatment available to her did not control her seizures. She recently made a 150-mile trip to the epilepsy clinic in Freetown. She was diagnosed with epilepsy and received Roweepra through one of our partners, Medical Assistance Sierra Leone (MASL).
September 20, 2018
THE REPUBLIC OF GEORGIA is the location of ROW’s latest equipment grant. Georgia shares a border with Armenia, the location of our very first grant in 2015. Now we’re providing the same Natus Neurology 32-channel video EEG workstation to the Georgian League Against Epilepsy.